ALVO Alvotech

NASDAQ
$5.32

Alvotech (ALVO) is expected to report earnings on November 18, 2026, after the market close. The consensus earnings estimate is $0.00 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +36.8% since its last earnings release on August 19, 2026.

Alvotech Missed Consensus Estimates, Reaffirms
Wednesday, August 19, 2026 · 4:30 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 18
Wednesday · 4:30 PM ET
Earnings Whisper
-
vs $0.00
Rev est $165.99M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.97

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Alvotech

Alvotech is a biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide.

Sector

Healthcare

Industry

Biotechnology